NIAGARA FALLS, N.Y.–(BUSINESS WIRE)–Cabbacis Inc (“Cabbacis” or the “Company”), a U.S. federally-licensed tobacco product manufacturer and plant biotech company focused on harm reduction products, announced today that investors can now participate in the Company’s Regulation A (Tier 2) initial public offering (IPO) through a capital raising portal. The Company has strategically chosen Issuance as its Regulation A, equity crowdfunding, platform portal. The Issuance platform conveniently accept
Source link
